This company has been acquired
Xybion Digital Valuation
Is XYBN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of XYBN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: XYBN (CA$0.9) is trading below our estimate of fair value (CA$3.3)
Significantly Below Fair Value: XYBN is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for XYBN?
Key metric: As XYBN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is XYBN's PE Ratio? | |
|---|---|
| PE Ratio | 35.9x |
| Earnings | US$960.03k |
| Market Cap | US$34.46m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.1x |
| Enterprise Value/EBITDA | 14.4x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does XYBN's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 56.4x | ||
VHI Vitalhub | 168.1x | 111.9% | CA$529.5m |
3671 Softmax | 11x | n/a | JP¥5.1b |
DR Medical Facilities | 13.6x | -30.0% | CA$369.6m |
VMD Viemed Healthcare | 33x | 49.4% | CA$311.8m |
XYBN Xybion Digital | 35.9x | n/a | CA$47.2m |
Price-To-Earnings vs Peers: XYBN is expensive based on its Price-To-Earnings Ratio (35.9x) compared to the peer average (31.5x).
Price to Earnings Ratio vs Industry
How does XYBN's PE Ratio compare vs other companies in the Global Healthcare Services Industry?
| 3 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: XYBN is expensive based on its Price-To-Earnings Ratio (35.9x) compared to the Global Healthcare Services industry average (28.8x).
Price to Earnings Ratio vs Fair Ratio
What is XYBN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 35.9x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate XYBN's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
NeuPath Health
CA$9.0m
Provides chronic pain management services in Canada.
NPTH
CA$0.16
7D
0%
1Y
3.2%
Medical Facilities
CA$369.6m
Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.
DR
CA$15.73
7D
4.4%
1Y
81.2%
Carebook Technologies
CA$6.2m
Engages in the development and commercialization of digital health platforms for assessments, reporting, and targeted solutions in Canada, the United States, Europe, Latin America, Asia, and internationally.
CRBK
CA$0.06
7D
-25.0%
1Y
-14.3%